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Abstract
Background: Exploring factors associated with retention in randomised trials provides insight into potential threats
to internal and external study validity, and may inform the development of interventions to increase retention in
future trials. Given a paucity of existing research in the field, a study was conducted to explore factors associated
with retention in a smoking intervention trial involving persons with a mental illness, considering
demographic and smoking characteristics, treatment condition and engagement in prior follow-up
assessments.
Method: A descriptive study was undertaken using data derived from a RCT of a smoking cessation intervention
initiated in four adult psychiatric inpatient units in New South Wales (NSW), Australia. Retention assessment was
undertaken at 1, 6 and 12-months post-discharge. A Generalised Linear Mixed Model was adopted to explore
associations between retention at any follow up time point and demographic and smoking characteristics. Chi
square analyses explored the association between retention at all follow up time points and treatment condition,
and binary logistic regression analyses assessed for relationships between retention at 12-month follow up and
engagement in prior follow up assessments.
Results: Retention rates were 63, 56 and 60% at the 1, 6 and 12-month assessments, respectively. No association was
found between retention at any follow-up time point and 13 of 15 demographic and smoking characteristics. Younger
participants and those who identified to be Aboriginal and/or Torres Strait Islander were more likely to be retained
(both ps > 0.05). Retention rates did not vary according to treatment condition at any follow-up time point.
Participants who completed a prior assessment were more likely to complete the 12 month assessment (both
prior assessments: OR 10.7, p< 0.001; 6month assessment: OR 6.01, p< 0.001; and 1month assessment: OR 1.8, p= 0.002).
Conclusion: The underrepresentation of younger participants and those identifying to be Aboriginal and/or Torres Strait
Islander may limit the generalisability of findings. Findings suggest that inclusion of multiple contacts during a trial follow
up period may increase retention at the final assessment. Interventions to improve retention, overall and for those sub-
groups less likely to be retained, in smoking trials involving persons with a mental illness are needed. Further
assessment of sample characteristics, and also trial design factors, associated with retention in this field is
warranted.
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Background
Tobacco smoking remains a leading cause of preventable
morbidity and mortality worldwide [1]. In high income
countries [2, 3] including Australia [4, 5], the prevalence
of smoking remains disproportionately high among
some population groups such as those with a diagnosed
mental illness [6–8], where the prevalence has been esti-
mated between 36 and 67% [9–11]. More rigorous inter-
vention research tailored to smokers with a mental
illness has been recommended to address the associated
inequitable health burden [12, 13].
Low rates of participant retention at trial end-points
or differential retention rates between treatment condi-
tions can compromise the internal (inference that the
intervention alone caused changes to outcome, through
minimisation of potential confounding variables) and ex-
ternal (generalisability) validity and reduce the statistical
power of controlled trials [14, 15]. As a result, the Con-
solidated Standards of Reporting Trials (CONSORT)
statement [16] specifies that trials report retention rates
overall and by each treatment condition separately.
Given the risk of bias in trial results due to inadequate
or differential participant retention, the development of
novel approaches to increase retention rates has been
identified as a priority for trial methods research [17].
Examining differences in the characteristics of partici-
pants retained and not retained has been suggested to
provide insight into the validity of trial outcomes [18].
In the case of smoking cessation trials generally, differ-
ences in smoking-related behaviours and characteristics
(such as motivation to quit or nicotine dependence)
between retained and not-retained participants has the
potential to confound trial results [15]. Given this, de-
scribing relationships between such participant charac-
teristics and trial retention rates is recommended to aid
the interpretation of reported trial findings [19]. Further,
describing the relationships between participant reten-
tion and trial design elements may inform the develop-
ment of interventions to increase retention rates in
smoking trials [17, 20].
Among adult smokers generally, systematic review evi-
dence suggests a variable relationship between partici-
pant retention and demographic characteristics such as
age, gender and socio-economic status [21]; and this re-
flects findings from broader behavioural research [22].
In terms of smoking characteristics, lower levels of
nicotine dependence [21, 23]; higher intention [21, 24],
self-efficacy [21, 25] and motivation [21] to quit; and
consumption of fewer cigarettes per day [21, 26] have
been associated with participant retention.
Three trials undertaken in the USA have reported on
the demographic and smoking characteristics associated
with retention in smoking intervention trials involving
persons with a mental illness [26–28]. Among smokers
residing in the community with either current or past
depression, gender, age, educational attainment and so-
cioeconomic status were found to be unrelated to the
stage that ‘drop out’ occurred (early, late and treatment
completers) [26]; whereas less severe current depressive
symptomology and consumption of fewer cigarettes per
day were associated with ‘drop out’ stage [26]. In a trial
involving psychiatric inpatients, participants without a
co-morbid alcohol use disorder and those who earned a
higher income were more likely to be retained at
3-months follow-up [27]. No smoking characteristics
were found to be associated with retention [27]. In a fur-
ther trial involving psychiatric inpatients, only readiness
to quit at baseline was positively associated with reten-
tion [28]. No Australian research has examined demo-
graphic and smoking characteristics associated with
retention in smoking trials involving persons with a
mental illness.
Given the limited previous research, a study was con-
ducted to explore factors associated with retention in a
smoking intervention trial involving persons with a men-
tal illness in Australia, considering demographic and
smoking characteristics, treatment condition and en-
gagement in prior follow-up assessments.
Methods
Design and setting
A descriptive study was undertaken using data derived
from a two-arm, parallel group randomised controlled
trial (RCT) of a smoking cessation intervention initiated
in four adult psychiatric inpatient units in New South
Wales (NSW), Australia and continued for 4 months
post-discharge. Randomisation was carried out separ-
ately by unit and stratified by diagnosis (psychotic/non-
psychotic) using a 1:1 allocation ratio. Participants allo-
cated to the control condition received care as usual for
smoking in the inpatient setting and following discharge.
Those in the intervention condition, during the inpatient
stay, received a brief motivational interview and written
self-help material for smoking cessation; and following
discharge, 16 weeks of telephone counselling and 12
weeks of fully subsidised nicotine replacement therapy.
Follow-up assessments were undertaken at 1, 6 and 12
months post-discharge. The methods and outcomes of
the trial have been previously reported [29, 30].
Sample and recruitment procedure
Between October 2012 and April 2014, research staff li-
aised with nurse unit managers daily to identify new pa-
tients sufficiently clinically stable to be approached and
assessed for study eligibility. Research staff were inde-
pendent of the hospitals, received standardised training
in mental illness and its impacts, and had completed or
were in the process of completing an undergraduate
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degree in a health related area. To be eligible, patients:
smoked any number of cigarettes in the month prior to
hospital admission; were18 years of age or above; could
provide informed consent; and had a current telephone
number. Smokers did not have to be motivated to quit
to participate in the trial. Eligible and consenting pa-
tients completed a baseline interview and were then ran-
domly allocated to either a control or intervention
condition (see [29] for the trial protocol).
Retention strategies
The trial adopted several strategies that have been iden-
tified to increase retention in smoking cessation and
other research fields, including: provision of reminders
for upcoming assessments (via text or postal letter)
[20, 31, 32]; reimbursement with a $20 supermarket
voucher upon completion of each follow-up assess-
ment [31, 33]; multiple (10) attempts to contact partici-
pants at each follow up point; collection of multiple
contact details (landline and mobile phone numbers,
email) for the participant, and the name and contact de-
tails of an elected contact person [20, 32, 33] and of their
general practitioner (if applicable) [20, 32, 33].
Data collection procedure
Participant retention was recorded by project staff conduct-
ing the computer-assisted telephone interview (CATI) at 1,
6 and 12months post discharge (November 2012 to June
2015). Participants were called at each time point, irrespect-
ive of their completion status at a prior assessment. CATIs
were the sole mode of follow-up data collection for the trial.
Participant characteristics of smoking and demographic
data were collected for all participants via face-to-face
interview during the inpatient stay. Other clinical and
demographic information was obtained via the patient
electronic medical record system at discharge.
Measures
Participant retention
Retention was measured at the 1, 6 and 12month post
-discharge follow-up assessment. Participants were con-
sidered ‘retained’ if they fully or partially (answered at
least questions assessing current smoking behaviour)
completed the follow-up assessment.
Demographic information
The following demographic information was obtained
from via face-to-face interview during the inpatient stay:
employment details (full time, part time, household duties,
student, unemployed/ other), education (primary school,
third year of high school, school certificate (fourth year
high school), Higher School Certificate (HSC; sixth year
high school), tertiary qualification not obtained from a
university, bachelor degree, post graduate degree) and liv-
ing circumstances (on own, with others).
The following data were collected from the patient
electronic medical record system at the time of dis-
charge: primary mental health diagnosis (schizophrenia
and related psychoses, anxiety and stress related disor-
ders, mood disorders, substance- related disorders, per-
sonality and other disorders), age, gender, relationship
status (single, married/de facto, separated/divorced,
widowed, did not state/inadequately described),Aborigi-
nal and/or Torres Strait Islander status (Aboriginal and/
or Torres Strait Islander, neither, did not state), legal sta-
tus at admission (voluntary, involuntary), and length of
stay (number of days between admission and discharge).
Smoking characteristics
Smoking characteristics collected via face-to-face inter-
view in the inpatient setting included: smoking status
(daily smoker, weekly smoker, irregular smoker [smoked
cigarettes less than weekly), cigarettes per day, level of
nicotine dependence (Fagerstrom Test for Nicotine
Dependence [FTND]) [34], ‘readiness’ to quit smoking
(Readiness to Quit Smoking Questionnaire [35]), and
number of quit attempts in the past 6 months (0, ≥1).
Variable transformation
The following variables were categorised to two levels for
association analyses: diagnosis (psychosis, non-psychosis),
Aboriginal and Torres Strait Islander status (Aboriginal
and/or Torres Strait Islander, neither Aboriginal nor
Torres Strait Islander), employment status (paid work-
force, unpaid workforce), educational attainment (HSC or
lower, tertiary), relationship status (currently partnered,
not-partnered/single), smoking status (daily smoker,
weekly/ irregular smoker), nicotine dependence (low-mo-
derate [FTND score ≤ 5], high [FTND score ≥ 6]) [36], and
readiness to quit (pre-contemplative, contemplative or a
more progressed stage). Age was reduced to four levels:
(18–25, 26–35, 36–50, 51+) [37].
Analyses
Analyses were conducted using IBM SPSS Statistics 22 [38].
Descriptive statistics were used to report on overall re-
tention rates, and according to condition of allocation.
McNemar tests assessed for differences in retention rate
at the 1, 6 and 12 month follow-up assessments.
Due to multiple pairwise comparisons in this study, a priori
all analyses were conducted with a type I error of ∝= 0.01.
Demographics and smoking characteristics associated with
retention at any follow-up time point
A generalised linear mixed model (GLMM) was adopted
to model participant retention (dependent variable) at
any follow-up assessment, and explore potential
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associations between retention and demographic and
smoking characteristics. A compound symmetry residual
covariance structure was used to model correlation asso-
ciated with repeated time measurements. All measures
included in Table 1 were considered as independent
variables in the GLMM. Characteristics associated with
retention at any follow-up time point were determined
via significant main effects. Allocation was entered and
retained in the model for control purposes.
Association between retention and treatment condition at
all follow-up time points
Chi square analyses assessed potential variations in re-
tention rate according to treatment condition, at each
follow-up assessment.
Association between retention at 1 and 6month follow-up
assessments, and retention at 12 months
Binary logistic regression was used to explore associa-
tions between retention at 1 and 6month assessments,
with retention at 12 months. Interactions between reten-
tion status at 1 and 6month assessments and condition
of allocation were also entered into the model.
Results
Sample
Three thousand six hundred and twenty-six patients
were admitted to the psychiatric inpatient facilities dur-
ing the recruitment period; 2078 were assessed for eligi-
bility, and 61% (N = 754) of eligible smokers were
recruited into the smoking cessation intervention trial
(Fig. 1). Fourteen participants were excluded from this
study due to being deceased (n = 11) or not discharged
from hospital (n = 3) at project completion - leaving 367
and 373 in the control and intervention condition, re-
spectively. Participant demographic information and
smoking characteristics, by treat condition, are sum-
marised in Table 1.
Participant retention
The rate of participant retention did not vary between
the 1 and 12 month post-discharge assessments (63%
versus 60%, p = 0.13) or the 6 and 12 month assessments
(56% versus 60%, p = 0.112). However, significantly more
participants were retained at the 1 month compared
to 6 month follow-up assessment (63% versus 56%,
p = 0.001).
Demographics and smoking characteristics associated
with retention at any follow-up time point
The large majority (13/15) of demographic and smoking
characteristics considered were not associated with re-
tention at any follow-up time point (ps > 0.05). Retention
was found to be significantly associated with age and
Aboriginal and Torres Strait Islander status. The likeli-
hood of retention was lower for those aged 18–25 (OR
0.83, 95% CI 0.75 to 0.91, p < 0.001), 26–35 (OR 0.88,
95% CI 0.80 to 0.95, p = 0.003) and 35–50 (OR 0.88, 95%
CI 0.81 to 0.95, p = 0.002) compared to those aged 51
and over; and for those who identified to be Aboriginal
and/or Torres Strait Islander, relative to those who did
not (OR 0.88, 95% CI 0.81 to 0.95, p = 0.002).
Association between retention and treatment condition
at all follow-up time points
There was no evidence of differential retention between
treatment conditions at any follow-up assessment (Table 2).
Association between retention at 1 and 6month follow-up
assessments, and retention at 12months
The odds of retention at the 12 month post-discharge
assessment were 1.8 (95% CI 1.25 to 2.59, p = 0.002)
times higher for those retained at 1 month, compared to
those who were not. The odds of retention at the 12
month post-discharge assessment were 6.01 (95% CI
4.20 to 8.60, p < 0.001) times higher for those retained at
6-months, relative to those who were not. Participants
retained at either the 1 or the 6 month post-discharge
Table 1 Baseline participant demographic information and







Agea 38.30 (12.01) 39.08 (11.96) 38.69 (11.99)
Age initiated smokinga 15.45 (4.40) 15.61 (4.83) 15.53 (4.62)
Length of staya (days) 13.36 (15.92) 15.11 (18.78) 14.24 (17.43)
Cigarettes smoked per daya 21.02 (13.19) 21.81 (14.49) 21.42 (13.86)
Genderb (male) 224 (61%) 228 (61%) 452 (61%)
Cultural backgroundb (ATSI) 48 (13%) 23 (14%) 101 (14%)
Diagnosisb (psychosis) 82 (22%) 84 (23%) 166 (22%)
Legal statusb (involuntary) 167 (46%) 179 (48%) 346 (47%)
Relationship statusb (single) 279 (76%) 306 (82%) 585 (79%)
Living circumstancesb (own) 103 (28%) 116 (31%) 219 (30%)
Highest education levelb
(HSC or lower)
258 (70%) 292 (78%) 550 (74%)
Employment statusb
(unpaid workforce)
267 (73%) 277 (74%) 544 (74%)
Type of smokerb (daily) 342 (93%) 348 (93%) 690 (93%)
Readiness to quitb
(pre-contemplation)
200 (55%) 207 (56%) 407 (55%)
Number of quit attemptsb
(at least one)
107 (29%) 121 (32%) 228 (31%)
Nicotine dependenceb (high) 189 (52%) 192 (52%) 381 (52%)
aMean (SD); bNumber (%); ATSI: Identify to be Aboriginal and/or Torres
Strait Islander origin; HSC: Higher School Certificate. Note. Table 1
presents summarised clinical, demographic and smoking characteristic data.
For non-summarised data, please see Table 1 in Metse et al. [30]
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assessment were 2.4 times more likely than those who
had completed no previous assessments to be retained
at 12 months (95% CI 1.58 to 3.61, p < 0.001). While
those who completed both prior assessments were 10.7
times more likely to be retained at 12 months (95% CI
7.12 to 16.11, p < 0.001) than those who had completed
neither assessment. Likelihood of retention contingent
on previous assessment completion status did not vary
according to allocation condition.
Of the 201 participants not retained at either the 1 or
6 month assessment, 30% (n = 60) were retained at 12
months. Similarly, 51% (99/196) of participants who
Fig. 1 Participant flow diagram
Table 2 Participant retention at 1, 6 and 12months post-discharge
by condition
Follow-up Assessment Control (n = 367) Intervention (n = 373) p
1 month 232 (63%) 233 (62%) 0.833
6 month 211 (58%) 206 (55%) 0.534
12 month 215 (59%) 225 (60%) 0.630
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completed only one of the prior assessments completed
the 12 months assessment.
Discussion
Low rates of participant retention or differential reten-
tion can compromise the internal and external validity
of controlled trials [14, 15]. Examining differences in the
characteristics of participants retained versus those who
are not has been suggested to provide insight into
threats to trial validity [18], and may inform interven-
tions to increase retention in future trials. This study
adds to a very limited literature [26–28] exploring fac-
tors associated with retention of persons with a mental
illness in smoking cessation trials. While 13 of 15 the
demographic and smoking characteristics considered
were not associated with retention, it was found that
younger participants and those who identified to be
Aboriginal and/or Torres Strait Islander were less likely
to be retained, suggesting they are underrepresented
which could limit the generalisability of findings. No
smoking characteristics were found to be associated with
retention, and there was no evidence of differential re-
tention between treatment conditions. This study also
assessed the association between completion of prior
follow-up assessments and retention at the trial end
point, with results suggesting a significant positive rela-
tionship. Findings indicate additional approaches to im-
prove retention in smoking cessation trials involving
persons with a mental illness are needed, both overall
and for sub-groups identified to be underrepresented in
this study. The inclusion of multiple contacts across
a trial follow up period may increase participant reten-
tion at the final assessment. Retrospective, systematic
identification of sample and trial design factors associ-
ated with participant retention in smoking cessation tri-
als involving persons with a mental illness is needed to
inform the development of interventions to increase re-
tention rates, tailored to the field.
The demographic characteristics found to be associ-
ated with retention in the current study were similar to
those reported for other studies, both within and outside
the field of smoking research. In terms of participant
age, research across the health behaviour change field
broadly has demonstrated that older participants are
more likely to remain engaged in research trials [39–41],
with such a trend also evident in smoking intervention
research [21]. To ensure younger persons with a mental
illness are represented in trials of smoking cessation in-
terventions, approaches to increase retention are needed.
For example, this subgroup has been shown to prefer a
more personal mode of follow-up (face-to-face rather
than online/telephone surveys; [42]). Choice of participa-
tion mode has also been shown to increase retention
[43], therefore, offerring the options of more and less
personal follow-up modes may be an intervention to in-
crease retention of young persons in smoking cessation
intervention trials. Further research is needed to deter-
mine the impact of such an approach.
The finding that participants who identified to be of
Aboriginal and/or Torres Strait Islander origin had a
lesser likelihood of being retained is congruent with that
of previous health behaviour research involving indigen-
ous minority groups [44–46], including those focussed
on smoking cessation interventions [21]. Limited re-
search has described possible strategies for increasing
retention of such participants in research trials [33]. Cul-
tural tailoring is one approach that may improve engage-
ment and in turn, retention [47, 48]. Cultural tailoring
involves the consideration of a target population’s eth-
nic/cultural characteristics, experiences, norms, values,
behavioural patterns and beliefs, as well as relevant his-
torical, environmental, and social forces when designing,
delivering, and evaluating a health behaviour trial [49].
Assessment of the impact on retention of culturally tai-
loring interventions to reduce smoking among per-
sons with a mental illness who identify as Aboriginal
or Torres Strait Islander is needed [47, 48].
No smoking characteristics were associated with reten-
tion in the current study, suggesting the trial outcomes
were not confounded [15]. These findings are similar to
those of a US study involving smokers admitted to in-
patient psychiatry, where smoking characteristics were
also found to be unrelated to retention [27].
The finding that participation in prior follow-up as-
sessments increased the likelihood of retention at the
final assessment is supportive of prior research suggest-
ing maintenance of contact with participants across the
follow-up period facilitates retention [33, 50, 51]. Such
results suggest that intermediate follow-up assessments
not only provide extended behaviour-change data, but
serve as a trial design strategy to improve retention at
the primary follow-up point.
In terms of existing evidence on strategies to increase
retention in trials, a Cochrane systematic review and
meta-analysis involving 38 trials across a spectrum of
disease areas found a significant effect of monetary in-
centives, tracking of postal questionnaires and open trial
designs [31]. The generalisability of findings across
follow-up methods, however, is somewhat limited as 34
of 38 included trials assessed response to postal or elec-
tronic questionnaires. Further, the broad inclusion cri-
teria for the review and heterogeneity of included
studies limited capacity to consider findings by popula-
tion group or disease area. Given retention rates are
likely impacted by unique factors within population
groups and disease areas [51], and the adoption of uni-
versal strategies to increase retention often have only a
modest impact, as is the case for the current study;
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targeted research is required to achieve meaningful in-
creases in retention rates in specific research fields.
The strengths of this study include its conduct with a
large and diverse sample of smokers with a mental ill-
ness and a 12-monthfollow-up period. However, partici-
pants were recruited across four psychiatric hospitals in
one regional local health district in NSW, Australia and
therefore findings may not be generalisable to samples
recruited from non-acute facilities, or for those residing
in capital cities or rural and remote areas. In addition,
full consideration of all factors that may have an impact
on retention, such as those related to the trial design/de-
livery and measures of participant motivation and char-
acteristics of recruiting staff [52], was outside the scope
of this paper and hence these may represent confound-
ing variables. Assessing factors associated with retention
for the intervention and control conditions separately
was also outside the scope of this paper. Finally, inter-
views were not conducted with those who withdrew
consent to participate, and as a result reasons for such
could not be included in the regression model. Never-
theless, the results of this study provide an indication of
the characteristics of persons with a mental illness, in an
Australian context, who may be less likely to be retained
in smoking trials, irrespective of the reason for
non-completion of follow-up assessments.
Conclusions
The underrepresentation of younger participants and
those identifying to be of Aboriginal and/or Torres Strait
Islander origin may limit the generalisability of findings
from the overarching RCT. Approaches to maximising
retention of these groups in future smoking trials involv-
ing persons with a mental illness are needed. Findings
suggested that inclusion of multiple contacts during a
trial follow up period may increase retention at the final
assessment.
To increase retention rates in smoking cessation trials
involving persons with a mental illness, further research
of high methodological rigour, such as a systematic re-
view, is needed to identify sample and trial design factors
associated with participant retention. Such research
would then inform the development of interventions/
strategies to maximise retention, tailored to the field.
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